BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T090000
DTEND;TZID=America/New_York:20200924T124500
DTSTAMP:20200922T011659Z
CREATED:20200922T010030Z
LAST-MODIFIED:20200922T011659Z
UID:47128-1600938000-1600951500@globalbiodefense.com
SUMMARY:The Biological Event Horizon: No Return or Total Resilience
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on Sep. 24 entitled\, “The Biological Event Horizon: No Return or Total Resilience“. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic is revealing major gaps in national readiness to prepare for\, respond to\, and recover from biological threats. Decision makers must consider enhancements to policies and programs to better defend against the next biological threat as the Nation continues to respond to the crisis. COVID-19 will not be the last biological threat we face and it likely will not be the worst as the risk of natural and human-generated threats continues to increase with time. \nAt this meeting\, the Commission intends to address these emerging biological threats and innovative science and technology solutions to address them. \nSpeakers include: \n\nJaime Yassif\, PhD: Senior Fellow\, Global Biological Policy and Programs\, Nuclear Threat Initiative\nSohini Ramachandran\, PhD: Associate Professor of Biology\, Director of Graduate Studies for the Center for Computational Molecular Biology\, Associate Professor of Computer Science\, Brown University\nNita Madhav\, MSPH\, Chief Executive Officer\, President\, and Board Member\, Metabiota\nRepresentative Susan Brooks (R-IN):  Member\, Subcommittee on Health\, Committee on Energy and Commerce\, U.S. House of Representatives\nRepresentative Diana DeGette (D-CO): Chair\, Subcommittee on Oversight and Investigation\, Committee on Energy and Commerce\, U.S. House of Representatives\nKavita M. Berger\, PhD: Director\, Board on Life Sciences\, National Academies of Sciences\nLuciana Borio\, MD: Vice President\, Technical Staff\, In-Q-Tel; Former Director for Medical and Biodefense Preparedness\, National Security Council; Former Assistant Commissioner for Counterterrorism Policy and Director\, Office of Counterterrorism and Emerging Threats\, Office of the Chief Scientist\, FDA; and Former Senior Medical Advisor\, Office of the ASPR\, DHHS\n\nPlease visit the Bipartisan Commission on Biodefense website for more information. \nGlobal Biodefense is not affiliated with the Bipartisan Commission on Biodefense and is providing this listing as a courtesy to the community.
URL:https://globalbiodefense.com/event/the-biological-event-horizon-no-return-or-total-resilience/
CATEGORIES:Policy-Legislative,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T130000
DTEND;TZID=America/New_York:20200924T143000
DTSTAMP:20200922T011528Z
CREATED:20200919T010636Z
LAST-MODIFIED:20200922T011528Z
UID:47130-1600952400-1600957800@globalbiodefense.com
SUMMARY:Clearing the Path: Responding to Disasters During a Crisis
DESCRIPTION:The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is convening a diverse group of public-private partners to present\, Clearing the Path: Responding to Disasters During a Crisis\, a virtual discussion for National Preparedness Month\, on September 24\, 2020\, from 1:00 p.m. – 2:30 p.m. EST. \nWhen responding to natural disasters during a crisis\, such as the COVID-19 pandemic\, emergency responders\, hospitals\, and supply chains are working at capacity\, while the next hurricane\, wildfire\, or flood could be around the corner. For communities to adapt and respond to these compounding pressures\, they must understand how technologies can inform risk-based decision making in areas of neighborhood health monitoring\, supply chains\, evacuation planning\, crisis communications\, and information sharing among front-line responders. Innovation in predictive analytics\, modeling and simulation\, and mobility offer new solutions to tackle immediate challenges and prepare for emerging threats. \nTopics of this virtual discussion will include: \n\nUnderstanding how public-private partnerships are accelerating new solutions and business models to prepare for day-to-day emergencies and a national crisis.\nEducating community leaders on how new science and technology applications are enhancing resilience and protecting life-line systems and networks.\nWith increased frequency of new threats\, examining what new tools and policies are available to incentivize collaboration among government\, industry\, and foundations.\nWith communities investing in automated and digital technologies\, asking why this is important and how predictive data sets are changing the way we think about risk and preparedness.\n\nSpeakers include: \n\nDavid Maurstad\, Deputy Associate Administrator\, FEMA\n\n\nDuane Caneva\, Chief Medical Officer\, DHS Countering WMD Office\n\n\nTed Smith\, Ph.D.\, Wastewater Based Epidemiology\, Professor of Environmental Medicine\, University of Louisville and Advisor to Louisville Mayor\, Greg Fischer\n\n\nCatherine Cross\, Deputy Under Secretary\, DHS Science and Technology Directorate (S&T)\n\n\nDavid Corman\, Program Director\, Cyber-Physical Systems and Smart and Connected Communities\, National Science Foundation\n\n\nRichard Seline\, Executive Director\, Accelerate H2O\, Houston\, TX\n\n\nMichel Leonard\, Vice President and Senior Economist\, Insurance Information Institute\n\n\nModerator: David Alexander\, Director of Resilience Research and Partnerships\, DHS S&T\n\nTo register for the National Preparedness Month Virtual Discussion: Clearing the Path: Responding to Disasters During a Crisis\, please register here.
URL:https://globalbiodefense.com/event/clearing-the-path-responding-to-disasters-during-a-crisis/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/national-preparedness-clearing-path-disaster-crisis-response-dhs.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200925T130000
DTEND;TZID=America/New_York:20200925T150000
DTSTAMP:20200922T225747Z
CREATED:20200922T225650Z
LAST-MODIFIED:20200922T225747Z
UID:47168-1601038800-1601046000@globalbiodefense.com
SUMMARY:COVID-19: Current State of the Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘COVID-19: Current State of the Pandemic” on 25 September 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the current pandemic hotspots in the US and globally\, including the epidemiology of the current wave of infections; discuss country-wide testing needs to mitigate and suppress COVID-19 infections; and review the evidence regarding possible re-infections of COVID-19\, and interpret the data behind the newest therapeutic guidelines for COVID-19. \nRegister here to attend the virtual event.
URL:https://globalbiodefense.com/event/covid-19-current-state-of-the-pandemic/
CATEGORIES:Conference,Continuing Education
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T090000
DTEND;TZID=America/New_York:20200929T163000
DTSTAMP:20200922T180748Z
CREATED:20200922T180416Z
LAST-MODIFIED:20200922T180748Z
UID:47143-1601370000-1601397000@globalbiodefense.com
SUMMARY:Pediatric Countermeasures: Children's National - NIAID Partnership Virtual Symposium
DESCRIPTION:A virtual symposium highlighting pediatric COVID-19 and MIS-C pandemic efforts undertaken by the NIAID-Children’s Hospital partnership will take place virtually on 29 September\, 2020. \nThis one day symposium bringing together investigators\, researchers\, and clinicians from the National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital as well as other interested participants from outside institutions\, to discuss the creation\, progress\, and evolution of this first-of-its-kind collaboration between the NIAID at the National Institutes of Health and Children’s National\, a pediatric academic medical center. \nThis year\, the event will highlight the current COVID-19 and MIS-C pandemic\, with a specific focus on the pediatric population. \nHighlighted speakers and topics include: \n\nOverview of SARS-CoV-2: Anthony S. Fauci\, MD (NIAID)\nRole of NCATS in the the SARS-CoV-2 Response: Christopher P. Austin\, MD (NCATS)\nHumoral Immune Response: Jeffrey I. Cohen\, MD (NIAID)\nCellular Response (T and NK Cells): Michael Keller\, MD (Children’s National)\nImmunopathogenesis of MIS-C: Sarah E. Henrickson\, MD\, PhD (CHOP)\nGenomic Factors in SARS-CoV-2: Helen Su\, MD\, PhD (NIAID)\nHealth Disparities and SARS-CoV-2: Akilah Jefferson Shah\, MD\, MSc (UAMS)\nClinical Spectrum of SARS-CoV-2\, Implication for Schools Reopening: Dan M. Cooper\, M.D. (UC Irvine)\nMIS-C and Post SARS-CoV-2 Monitoring in Children: Roberta DeBiasi\, MD\, MS (Children’s National)\nPost SARS-CoV-2 Monitoring in Adults: Michael C. Sneller\, MD (NIAID)\nOverview of Vaccine Candidates: Peter Hotez\, MD\, PhD (Baylor)\nCurrent State of Vaccine Clinical Trials: Julie Ledgerwood\, DO (NIAID)\nOngoing Therapeutic Trials and Treatment Guidelines: Cliff Lane\, M.D. (NIAID)\nSARS-CoV-2 What Comes Next – Societal/Economic Impact: Ezekiel Emanuel\, MD\, PhD (UPenn)\n\nIn 2017\, The National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital launched a clinical research partnership devoted to protecting and advancing the health of children with allergic\, immunologic\, auto-inflammatory\, and infectious disease through collaborative research and education. This strategic and novel alliance is supported through the Clinical and Translational Science Institute at Children’s National (CTSI-CN). The partnership\, co-led by H. Clifford Lane\, M.D.\, Deputy Director for Clinical Research and Special Projects at NIAID\, and Mark Batshaw\, M.D.\, Executive Vice President and Chief Academic Officer at Children’s National\, holds the mission to generate and apply knowledge to promote the prevention\, diagnosis\, treatment\, and cure of these childhood diseases through its work together. \nFor each area\, designated investigators from each institution are collaborating to design and conduct clinical research studies that will advance prevention strategies\, diagnoses\, treatments\, and cures for the diverse range of pediatric diseases involving the immune system. Many of these studies will include children at high risk for complications related to their underlying disease or to experimental therapeutics and diagnostic tests they receive. Research participants will have the opportunity to be seen at both Children’s National and the NIH Clinical Center in Bethesda\, Maryland. Together\, the two institutions provide comprehensive\, state-of-the-art pediatric clinical support\, infrastructure\, and research capacity. These resources protect the safety of children\, ensure that they receive the highest quality of care\, and offer them the opportunity to participate in cutting-edge clinical research. In addition\, the partnership established joint training opportunities for physician-scientists interested in caring for these children while developing their research expertise in pediatric immunology\, allergic\, and infectious diseases. \nThe collaboration is supported through an NIAID supplement to the Clinical and Translational Science Institute at Children’s National\, which is funded by a Clinical and Translational Science Award from NIH’s National Center for Advancing Translational Sciences to Children’s National Hospital and The George Washington University. \nRegister here. \n 
URL:https://globalbiodefense.com/event/pediatric-countermeasures-childrens-national-niaid-partnership-virtual-symposium/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/niaid-childrens-national-covid-19-research-countermeasures.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T110000
DTEND;TZID=America/New_York:20200929T130000
DTSTAMP:20200922T003739Z
CREATED:20200922T002936Z
LAST-MODIFIED:20200922T003739Z
UID:47124-1601377200-1601384400@globalbiodefense.com
SUMMARY:Preventing Global Catastrophic Biological Risks: 2020 Munich Security Conference Tabletop Exercise Report
DESCRIPTION:NTI will host a report release event on 29 September to review lessons and recommendations from NTI’s 2020 Munich Security Conference Tabletop Exercise\, presenting key recommendations for actions that international stakeholders can take to meaningfully reduce catastrophic biological risks. \nThe virtual event is moderated by Andrew Hebbeler\, Senior Director and Lead Scientist\, NTI Global Biological Policy and Programs. \nSpeakers include: \n\nErnest J. Moniz\, Co-Chair and CEO\, NTI\nElhadj As Sy\, Co-Chair\, Global Preparedness Monitoring Board\nEmily Leproust\, CEO\, Twist Bioscience\nJaime Yassif\, Senior Fellow\, NTI Global Biological Policy and Programs\n\nThe presentations will be followed by Q&A with attendees. \nPlease visit the NTI website for additional information.
URL:https://globalbiodefense.com/event/preventing-global-catastrophic-biological-risks-launch-event-for-ntis-2020-munich-security-conference-tabletop-exercise-report/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://zoom.us/webinar/register/WN_UOTGXaUMTguXnxs7ileOTw
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T090000
DTEND;TZID=America/New_York:20200930T160000
DTSTAMP:20200922T212454Z
CREATED:20200922T212454Z
LAST-MODIFIED:20200922T212454Z
UID:47156-1601456400-1601481600@globalbiodefense.com
SUMMARY:Biomedical Informatics and Data Sciences in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Biomedical Informatics and Data Sciences in Africa‘ on 30 September 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will address emerging opportunities and challenges in the application of Data Science and Informatics technologies in various biomedical domains. It will also highlight some key challenges in the areas of data mining\, data quality\, standards for various types of data\, in addition to addressing how cutting-edge data analytics\, predictive modeling and Machine Learning\, and methods for simulations can advance human health in Africa. \nModerator: \nDarrell Hurt\, National Institute of Allergy and Infectious Diseases\, National Institutes of Health (NIH) \nGeetha Senthil\, National Institute of Mental Health\, NIH\nPanelists:\nAgnes Abdoulaye Banire Diallo\, University of Quebec-Montreal (UQAM) \nElaine Nsoesie\, Boston University \nGeoffrey Siwo\, University of Notre Dame \nDina Machuve\, Nelson Mandela African Institution of Science and Technology \nMoustapha Cisse\, Google AI \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/biomedical-informatics-and-data-sciences-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T130000
DTEND;TZID=America/New_York:20200930T143000
DTSTAMP:20200927T191940Z
CREATED:20200827T174326Z
LAST-MODIFIED:20200927T191940Z
UID:47213-1601470800-1601476200@globalbiodefense.com
SUMMARY:DTRA Chemical and Biological Technologies Department: Student Workforce Opportunities
DESCRIPTION:The Defense Threat Reduction Agency’s Chemical and Biological Technologies Department (DTRA-CB) will host a University Engagement Webinar: Student Workforce Opportunities on Wednesday\, Sept. 30\, 2020. \nDuring this webinar\, participants will learn about internships\, scholarships\, fellowships\, postdoctoral and employment opportunities available through the DoD and federal government. \nTopics that will be discussed include: \n\nMore on DTRA-CB’s role as the DoD’s Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)\nNational Research Council (NRC) Research Associateship (Postdoctoral) Program\nPathways Programs: Pathways Internship Programs\, Recent Graduates Program and the Presidential Management Fellows Program (PMF)\nNavigating USAJOBS for employment opportunities\nScience\, Mathematics\, and Research for Transformation (SMART) Scholarship-for-Service Program benefits\, application deadlines and success stories\n\nLearn more: http://bit.ly/dtracbd-student-workforce
URL:https://globalbiodefense.com/event/dtra-chemical-and-biological-technologies-department-student-workforce-opportunities/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/08/defense-threat-reduction-chemical-biological-defense-dtra-cbd-jsto-university-engagement-global-biodefense.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T110000
DTSTAMP:20200927T192759Z
CREATED:20200927T192759Z
LAST-MODIFIED:20200927T192759Z
UID:47216-1601546400-1601550000@globalbiodefense.com
SUMMARY:Accelerating Detection of Disease: UKRI Industry Briefing for Life Sciences Sector
DESCRIPTION:The UK Research and Innovation (UKRI)-funded Accelerating Detection of Disease (ADD) program will host a webinar on 1 October 2020 for life science companies to learn more about partnering and investment opportunities. \nOver the next four years the ADD program will recruit five million volunteers to support research intended to improve early detection\, risk stratification\, and early intervention for chronic diseases. \nADD volunteers will provide biological samples and health related data. With their consent\, volunteers’ data will be linked to NHS records\, and ADD will also offer volunteers feedback about their health\, if they choose. Some will be invited to provide repeat samples and join follow-on studies designed to test the potential of new diagnostic tests or treatments\, particularly if they’re at higher risk for certain diseases. \nThe unrivalled depth and detail of the ADD initiative will make it a unique resource for health research. Researchers from across academia and industry will have the chance to work with ADD to conduct studies that could improve the way we detect\, diagnose and treat diseases. \nSpeakers at the seminar include: \n\nAlison Cave\, Accelerating Detection of Disease challenge director at UK Research and Innovation\nAndrew Roddam\, CEO\, Early Disease Detection Research Project UK Ltd\, the charity that runs the ADD programme\nFiona Reddington\, Exec Director of Partnerships\, Early Disease Detection Research Project UK Ltd.\n\nADD is funded by £79 million from UKRI’s Industrial Strategy Challenge Fund which is expected to be matched by funding of up to £160 million from industry.
URL:https://globalbiodefense.com/event/accelerating-detection-of-disease-ukri-industry-briefing-for-life-sciences-sector/
CATEGORIES:Industry Day,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201001T120000
DTEND;TZID=America/New_York:20201001T130000
DTSTAMP:20200923T194149Z
CREATED:20200923T194110Z
LAST-MODIFIED:20200923T194149Z
UID:47182-1601553600-1601557200@globalbiodefense.com
SUMMARY:HDIAC Webinar: Agnostic Compact Demilitarization of Chemical Agents
DESCRIPTION:Join HDIAC Thursday\, October 1\, from 1200 to 1300 EDT for our next webinar presentation titled “Agnostic Compact Demilitarization of Chemical Agents (ACDC).” \nPlease register in advance for the webinar at: https://www.anymeeting.com/PIID=EF54DD81854C3B \nThe safe destruction of chemical warfare agents (CWAs) and organic precursors is a timely\, costly\, and significant challenge for the international community. Today\, for example\, there are no approaches that exploit chemistries that are truly agnostic in terms of the agents that can be processed. Additionally\, current approaches require transport of agents from the storage site to a neutralization site\, which can add significant cost and time to the destruction process. \nDARPA’s ACDC program explored new technologies for neutralization of bulk stores of CWAs and organic precursors at or near the site of storage. ACDC developed and demonstrated the technologies needed to construct a transportable\, prototype system that converts organic compounds into constitutive carbon/nitrogen/phosphorous/sulfur oxides and stable alkali or alkaline earth metal salts. The ACDC system featured chemistries for agent destruction and sequestration of halogens and other components using locally available or easily transportable resources. This webinar describes the DARPA ACDC program and its exploration of neutralization of bulk stores of CWAs and organic precursors at or near the site of storage. \nABOUT THE SPEAKER \nMr. Darrel Johnston manages the Pharmaceutical Program and Pilot Plant Operations section of the Southwest Research Institute which works with government and commercial clients in the areas of drug modeling\, synthesis\, scale-up\, and production.    With reactors up to 200 liters\, he oversees the operation of a pilot plant facility compliant with current Good Manufacturing Practices\, Good Laboratory Practice\, and Drug Enforcement Agency controlled substances as needed.  Projects have included treatment or preventative drugs for cancer\, heart attack\, COVID-19\, EBOV\, SUDV\, MARV\, and poisoning from opioids\, organophosphates\, and cyanide. Mr. Johnston’s chemical demilitarization experience includes construction\, systemization\, start-up\, operations\, and closure phases of chemical warfare agent demilitarization at the Johnston Atoll Chemical Agent Destruction System (JACADS)\, Umatilla Chemical Agent Disposal Facility (UMCDF)\, Pine Bluff Chemical Agent Disposal Facility\, and Newport Chemical Agent Disposal Facility (NECDF).  He facilitated air sampling and analysis for chemical agent BZ\, for the demolition of the BZ Disposal Facility (BZDF) in Pine Bluff\, AR.  Mr. Johnston served as the on-site Laboratory Manager for the JACADS\, UMCDF\, and NECDF facilities and was responsible for leadership and day-to-day operation of the agent and non-agent monitoring systems including the analytical laboratories.  His direct support of demilitarization laboratory operations spanned 17 years from 1990-2008. Mr. Johnston was also the Southwest Research Institute project manager for the Defense Advanced Research Projects Agency (DARPA) Agnostic Compact Demilitarization of Chemicals (ACDC) project.  While serving in this role\, he investigated the use of a diesel engine for the destruction of chemical warfare agents and making use of media such as soil for acid gas scrubbing.
URL:https://globalbiodefense.com/event/hdiac-webinar-agnostic-compact-demilitarization-of-chemical-agents/
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/hdiac-webinar-agnostic-compact-demilitarization-chemical-agents.jpg
LOCATION:https://www.anymeeting.com/AccountManager/RegEv.aspx?PIID=EF54DD81854C3B
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201002T130000
DTEND;TZID=America/New_York:20201002T150000
DTSTAMP:20200923T002332Z
CREATED:20200923T002332Z
LAST-MODIFIED:20200923T002332Z
UID:47176-1601643600-1601650800@globalbiodefense.com
SUMMARY:Got Masks? PPE Compliance and Fatigue in First Responder Realms
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Got Masks? PPE Compliance and Fatigue in First Responder Realms‘ on 2 October 2020 as part of its virtual webinar series. \nAre personnel becoming less diligent with PPE? Is there a significant element of PPE fatigue? Do you know what the PPE requirements are when not actively providing patient care? What about PPE requirements in the office\, ambulance\, and firehouse? Join NETEC for a Town Hall meeting and discuss the importance of PPE in the First Responder Environment and learn techniques to deal with PPE fatigue and improve compliance? Submit your questions for the panel during registration and they will be answered during the Town Hall session. \nPlease register here: http://bit.ly/netec-ppe-compliance
URL:https://globalbiodefense.com/event/got-masks-ppe-compliance-and-fatigue-in-first-responder-realms/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201007T090000
DTEND;TZID=America/New_York:20201007T160000
DTSTAMP:20200922T214447Z
CREATED:20200922T214447Z
LAST-MODIFIED:20200922T214447Z
UID:47158-1602061200-1602086400@globalbiodefense.com
SUMMARY:Innovative Approaches to Improve Maternal and Child Health
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovative Approaches to Improve Maternal and Child Health‘ on 7 October 2020 as part of the DS-I Africa Virtual Forum series. \nMaternal and child health outcomes in Africa still lag behind the rest of the world despite prioritization as a topic of focus within the United Nations Sustainable Development Goals (SDGs). Partners from  country-level governments\, research institutions\, private sector program funding agencies and non-governmental organizations are involved in various capacities and across disciplines\, implementing activities to reduce the enormous burden of high mortality and morbidity of women and children on the African continent.  Nonetheless\, millions of women and children experience death and severe morbidity each year despite these efforts. In this session we will 1) address the gap in availability of existing databases and collective data focused on pregnancy and the peripartum period; 2) explore emerging use of linked data such as electronic medical records as a tool for conducting research\, analyzing data and creating tools for interventions; and 3) develop concrete recommendations for a strategy to utilize data science to improve maternal and child health outcomes from pre-pregnancy to pregnancy and delivery and throughout the mother and child’s life course. \nIntroductions:\nVesna Kutlesic\, US Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\, National Institutes of Health (NIH) \nDiana Bianchi\, Director of NICHD\, NIH \nNaveen Rao\, MD\, Senior Vice President & Senior Advisor to the President\, Health Initiative\, The Rockefeller Foundation \nModerator:\nDenise Russo\, NICHD\, NIH \nPanelists:\nAndre van der Kouwe\, Ph.D.\, Associate Professor in Radiology\, Harvard Medical School\, Assistant in Physics\, Massachusetts General Hospital \nLilla Zöllei\, Ph.D.\, Assistant Professor of Radiology\, Harvard Medical School \nMoses Alobo\, M.D.\, Program Manager\, Grand Challenges Africa Programme at African Academy of Sciences \nAlash’le Abimiku\, Ph.D.\, Professor in Epidemiology & Public Health\, University of Maryland School of Medicine; Executive Director\, International Research Center of Excellence at the Institute of Human Virology-Nigeria \nAmel Ghouila\, Ph.D.\, Bioinformatician\, Capacity Builder\, Pan African Bioinformatics \nTo participate in the discussion and session\, you must register for this DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovative-approaches-to-improve-maternal-and-child-health/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T090000
DTEND;TZID=America/New_York:20201014T160000
DTSTAMP:20200922T214817Z
CREATED:20200922T214735Z
LAST-MODIFIED:20200922T214817Z
UID:47160-1602666000-1602691200@globalbiodefense.com
SUMMARY:Using Data Science to Fight COVID-19
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Using Data Science to Fight COVID-19‘ on 14 October 2020 as part of the DS-I Africa Virtual Forum series. \nModerator:\nStefan Jaeger\, National Library of Medicine\, National Institutes of Health \nPanelists:\nAgnes Kiragga\, Ph.D.\, Head of Statistics and Data Management Unit and Senior Research Scientist\, Infectious Diseases Institute (IDI)\, Makerere University College of Health Sciences \nNirmal Ravi\, MD\, Ph.D. \nAli H. Mokdad\, Ph.D.\, Professor of Health Metrics Sciences\, the Institute for Health Metrics and Evaluation; Chief Strategy Officer\, Population Health at the University of Washington \nElaine Nsoesie\, Ph.D.\, Assistant Professor of Global Health\, Boston University School of Public Health \nFrank Kagoro\, Ph.D.\, Research Physician\, MORU Tropical Health Network and WorldWide Antimalarial Resistance Network \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/using-data-science-to-fight-covid-19/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201016T130000
DTEND;TZID=America/New_York:20201016T150000
DTSTAMP:20200923T001907Z
CREATED:20200923T001702Z
LAST-MODIFIED:20200923T001907Z
UID:47174-1602853200-1602860400@globalbiodefense.com
SUMMARY:Pediatric Perspectives During a Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Pediatric Perspectives During a Pandemic” on 16 October 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the epidemiology of acute COVID-19\, including post-infectious manifestations and the unique aspects of caring for children during a pandemic. NETEC will also discuss the features of MIS-C and how to devise a diagnostic and acute management plan and integrate potential post-recovery complications into the development of follow-up plans for a child with MIS-C. \nRegister for the event here: http://bit.ly/netec-pediatric-pandemic
URL:https://globalbiodefense.com/event/pediatric-perspectives-during-a-pandemic/
CATEGORIES:Continuing Education,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20201016T140000
DTEND;TZID=America/Los_Angeles:20201016T163000
DTSTAMP:20201006T183317Z
CREATED:20201006T183317Z
LAST-MODIFIED:20201006T183317Z
UID:47329-1602856800-1602865800@globalbiodefense.com
SUMMARY:Effects of the COVID-19 Pandemic on the Life Science Enterprise
DESCRIPTION:The National Academies’ Board on Life Sciences will host two panel sessions on October 16 on Effects of the COVID-19 Pandemic on the Life Science Enterprise and Inequities in the Life Sciences: Understanding the Issues. \nHow has the COVID-19 pandemic affected research\, education\, and workforce in the life sciences? This session will explore short and long-term consequences of the pandemic on life science research\, education and training\, career progression as a first step to examining resiliency within the life science research enterprise. \nInequities in the Life Sciences: Understanding the Issues \n2:00-3:00 PM \nHow do such factors as gender\, race\, and socioeconomic level affect educational\, research\, and career opportunities in the life sciences? This session will explore consequences associated with inequities in the life sciences\, needs for preventing societal injustices\, and opportunities for addressing those needs. \nSession moderator: Keegan Sawyer\, National Academies’ Board on Life Sciences \nPanelists: \n\nScott V. Edwards\, Harvard University\nPaul Barber\, University of California Los Angeles\nEdie M. Stringfellow\, MassBio\nPaul Turner\, Yale University\nShirley Malcom\, SEA Change\, American Association for the Advancement of Science\n\nEffects of the COVID-19 Pandemic on the Life Science Enterprise \n3:10-4:40 PM \nSession moderator: Nancy Connell\, Johns Hopkins Center for Health Security \nPanelists: \n\nSusan Singer\, Rollins College\nArielle Baker\, National Academies of Sciences\, Engineering\, and Medicine\nJan O. Korbel\, European Molecular Biology Laboratory\nErik Prentice\, 6F\nHolden Thorp\, AAAS/Science\nMarc Malandro\, Chan Zuckerberg Initiative\nMark Alexander\, 100 Black Men of America\, Inc\n\nThese sessions will be live streamed on the Board on Life Science website \nLearn more: http://bit.ly/nasemlifesciences \n 
URL:https://globalbiodefense.com/event/effects-of-the-covid-19-pandemic-on-the-life-science-enterprise/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20201021T090000
DTEND;TZID=America/Los_Angeles:20201021T160000
DTSTAMP:20200922T215239Z
CREATED:20200922T215225Z
LAST-MODIFIED:20200922T215239Z
UID:47162-1603270800-1603296000@globalbiodefense.com
SUMMARY:Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa‘ on 21 October 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will highlight the emerging field of health metrics sciences and its role in measuring and monitoring summary measures of health in Africa to better develop and implement measures to reduce the burden of disease. Identify challenges and opportunities relevant to the DS-I Africa initiatives. Address the increasing role that health metrics is playing in informing and prioritizing systems-level health interventions and broad public health-related decision making. Discuss how health metrics and data science can inform and evaluate more effective integrated care efforts at the intersection of infectious diseases and the rapidly growing burden of chronic\, non-communicable diseases \nModerator:\nKaren Sliwa\, University of Cape Town \nPanelists:\nMayowa Ojo Owolabi\, University of Ibadan \nDebbie Bradshaw\, South African Medical Research Council \nAna Olga H Mocumbi\, Mondlane University \nAli H. Mokdad\, Institute for Health Metrics and Evaluation \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovations-in-health-metrics-sciences-measuring-mapping-and-monitoring-morbidity-and-mortality-at-the-regional-national-and-local-levels-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201021T120000
DTEND;TZID=America/New_York:20201021T133000
DTSTAMP:20201006T184848Z
CREATED:20201006T184848Z
LAST-MODIFIED:20201006T184848Z
UID:47335-1603281600-1603287000@globalbiodefense.com
SUMMARY:Digital Genetic Sequences and International Data Sharing Policies
DESCRIPTION:The National Academies’ Board on Life Sciences will host a virtual panel discussion on October 21\, 2020 on Digital Genetic Sequences and International Data Sharing Policies. \n\nHow does the complex policy environment affect sharing of genetic sequence data internationally to address critical and pressing societal needs? This session will explore the implications of ongoing international discussions associated with sharing genetic sequence data. What policy frameworks govern the collection and sharing of digital sequence information around the world? What considerations are important for balancing open access and protection of genetic sequence data? \nSession moderator: Todd Kiuken\, North Carolina State University. \nPanelists: \n\nPatrick Reilly\, Department of State\nIan Watson\, Department of Health and Human Services\nDiane DiEuliis\, National Defense University\nHarris Lewin\, Earth BioGenome Project\n\nLearn more: http://bit.ly/nasem-lifesci-oct2020
URL:https://globalbiodefense.com/event/digital-genetic-sequences-and-international-data-sharing-policies/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201021T134500
DTEND;TZID=America/New_York:20201021T150000
DTSTAMP:20201006T184647Z
CREATED:20201006T184252Z
LAST-MODIFIED:20201006T184647Z
UID:47333-1603287900-1603292400@globalbiodefense.com
SUMMARY:Biotechnology Innovations in the 21st Century
DESCRIPTION:The National Academies’ Board on Life Sciences will host a virtual panel discussion on October 21\, 2020 on Biotechnology Innovations in the 21st Century. \n\nHow is the convergence of the life sciences with other scientific disciplines and fields enabling new capabilities beyond medicine and agriculture? This session will explore innovations in biotechnology that leverage advances in several scientific disciplines\, enabling new applications and enhancing the bioeconomy. \nSession moderator: Clem Fortman\, Engineering Biology Research Consortium \nPanelists: \n\nKerri Dugan\, Defense Advanced Research Projects Agency\nMichelle Rozo\, Department of Defense\nTodd Anderson\, Department of Energy\nJohn Beieler\, Office of the Director of National Intelligence\nTheresa Good\, National Science Foundation\nElizabeth Strychalski\, National Institute of Standards and Technology\n\n\n\nLearn more: http://bit.ly/nasem-lifesci-oct2020
URL:https://globalbiodefense.com/event/biotechnology-innovations-in-the-21st-century/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201022T100000
DTEND;TZID=America/New_York:20201022T170000
DTSTAMP:20200927T172033Z
CREATED:20200927T172033Z
LAST-MODIFIED:20200927T172033Z
UID:47197-1603360800-1603386000@globalbiodefense.com
SUMMARY:FDA Vaccines and Related Biological Products Advisory Committee Meeting
DESCRIPTION:On October 22\, 2020\, the Center for Biologics Evaluation and Research’s (CBER)\, Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session\, to discuss\, in general\, the development\, authorization and/or licensure of vaccines to prevent COVID-19. No specific application will be discussed at this meeting. \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nThe meeting will include slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. \n\nWritten submissions may be made to the contact person on or before October 15\, 2020.\nOn October 22\, 2020\, oral presentations from the public will be scheduled between approximately 2:30 p.m. and 3:30 p.m. EST.\n\nThose individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present\, the names and addresses of proposed participants\, and an indication of the approximate time requested to make their presentation on or before October 7\, 2020. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session\, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 8\, 2020. \nWebcast Information\nCBER plans to provide a free of charge\, live webcast of the Vaccines and Related Biological Products Advisory Committee meeting. If there are instances where the webcast transmission is not successful; staff will work to re-establish the transmission as soon as possible. \nThe online web conference meeting will be available at:\nhttp://fda.yorkcast.com/webcast/Play/c26e83a0f77a412296949f4f43af4c981d
URL:https://globalbiodefense.com/event/fda-vaccines-and-related-biological-products-advisory-committee-meeting/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201028
DTSTAMP:20200927T165438Z
CREATED:20200802T163328Z
LAST-MODIFIED:20200927T165438Z
UID:47192-1603756800-1603843199@globalbiodefense.com
SUMMARY:BARDA Industry Day 2020
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA) will host a virtual Industry Day on October 27\, 2020 to learn about U.S. Government medical countermeasure priorities\, interact with the BARDA and HHS ASPR teams\, and network with public and private sector colleagues. \nFeatured speakers and breakout presenters will address the many ways BARDA is actively addressing the current COVID-19 pandemic crisis and forging new partnerships while remaining vigilant and prepared for any new threats that may arise. \nBARDA Industry Day 2020 will include breakout sessions\, virtual networking opportunities\, and an address by Acting BARDA Director\, Dr. Gary Disbrow. Lightning Talk sessions will be available to selected applicants\, which provide an opportunity to present their technologies to an audience of BARDA specialists\, industry partners\, and potential collaborators. \nThe conference is open to anyone in the public who wishes to attend. The content is mainly geared towards healthcare research professionals and medical countermeasure developers\, government agency staff\, pharmaceutical professionals\, and scientific researchers and academics. \nThe breakout sessions and plenary discussions will be available for viewing on the conference website after the event \nLearn more: http://bit.ly/bardaindustryday2020 \nEditor’s Update 31 Aug: The Lightning Talks application submission period is now closed. Event registration is still open.
URL:https://globalbiodefense.com/event/barda-industry-day-2020/
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/barda-industry-day-2020.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201031
DTSTAMP:20200922T181413Z
CREATED:20200922T181413Z
LAST-MODIFIED:20200922T181413Z
UID:47146-1603756800-1604102399@globalbiodefense.com
SUMMARY:NIH Program Funding and Grants Administration Virtual Seminar
DESCRIPTION:The National Institutes of Health invites you to take part in a unique opportunity to learn more about\nworking with the NIH grants process\, programs\, policies\, and staff at the 2020 NIH Virtual Seminar on Grants Administration and Program Funding 27-30 October 2020. \nThis seminar is designed for those who are new to working with the NIH grants process – administrators\, early stage investigators\, researchers\, graduate students\, etc. For those with more experience\, NIH experts provide a few sessions that are designed for participants that are more advanced and are focused on more in-depth polices and processes. \nWhat to expect?\nYou may be familiar with the NIH Regional Seminar and wondering if this is the same event moved to a virtual environment. There are some similarities\, but also some modifications to accommodate the new format. \n\nThis event is scheduled over four days in the afternoons only (U.S. New York time zone – EDT). Sessions 1:00 PM – 5:45 PM\nThere are three tracks of sessions which are open to any participants on any given day without any further registration.\nAll sessions are 45-minute sessions with a 15 minute break before the next session begins. Some are live\, while others are simulive (a combination of a pre-recorded video and live Q&A).\nRepresentatives from NIH programs\, offices\, and Institutes and Centers will be presenting and attending booths in the Meet the Experts Exhibit Hall.\nThe seminar is free!\n\nTuesday\, October 27 – Thursday\, October 29 \n\n\nTrack 1\nNIH Grant Process \n\n\nLooking for an overview of the NIH Grant Process from application preparation to post-award management? This is the track for you! \n\n\n\n\nTrack 2\nNIH Grant Policies & Programs \n\n\nWanting to learn about specific programs offered by NIH or receive updates on the latest NIH & HHS policies? Check out this track. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nSessions in this track are designed to be more interactive with Question & Answer sessions and case studies. \n\n\nFriday\, October 30 \nTracks are slightly different with sessions that are primarily focused on a general topic or program: \n\n\nSpecial Focus 1:\nHuman Subjects in Research \n\n\nIf your research meets the definition of involving human subjects\, then you’ll want to participate in these sessions provided by OHRP and NIH. \n\n\n\n\nSpecial Focus 2:\nSEEDing the Marketplace \n\n\nThe NIH SEED (Small business Entrepreneurial Education) team is providing a track focused on developing relationships and building relationshops for innovators to move towards production. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nVisit this track for sessions focused on business\, inventions\, and data. Visit for more interactive with Q&A and/or case studies. \n\n\nWho are the Presenters?\nThis seminar involves over 50 NIH and HHS presenters and over 100 additional experts at the NIH booths who are eager to educate\, share\, and hear your questions during this event. It’s your opportunity to interact with NIH policy officials\, grants management\, program and review staff\, and representatives from the HHS Office for Human Research Protections (OHRP) and HHS Office of Research Integrity. Select the “Presenters” tab to see a selection of NIH & HHS experts who will be providing presentations. \nView the full AGENDA \nRegister HERE.
URL:https://globalbiodefense.com/event/nih-program-funding-and-grants-administration-virtual-seminar/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T133000
DTEND;TZID=America/New_York:20201027T163000
DTSTAMP:20201023T154239Z
CREATED:20201012T153755Z
LAST-MODIFIED:20201023T154239Z
UID:47618-1603805400-1603816200@globalbiodefense.com
SUMMARY:COVID-19 and the Geography of Vulnerability
DESCRIPTION:The National Academies Geographical Sciences Committee will host a virtual keynote talk on Oct. 27 on “COVID-19 and the Geography of Vulnerability“. \nOur understanding of the geographic spread of COVID-19 has largely been based on national-scale epidemiological models\, while the place-based responses to community-level impacts of the disease have mainly been informed by local-scale surveys and reports of the lived experiences of individuals within those communities. Geographers have the capacity to integrate local and population-scale research\, yet examples of this type of integration are rare among studies of vulnerability. \nDuring this meeting\, the National Academies’ Geographical Sciences Committee will examine the geography of vulnerability in the context of the COVID-19 pandemic. This meeting will be held to discuss the following questions and consider potential next steps that could be taken to advance the capacity to characterize\, predict\, and alleviate vulnerability. \nFeaturing Keynote Talk by Dr. Eric Tate\, Associate Professor\, University of Iowa\nSocial Vulnerability and Place-based Risk \nPanelists \nDr. Elisabeth Root\, Professor\, Ohio State University: Identifying Vulnerability from the COVID-19 Data: What is Possible and What is Missing? \nDr. Peter Smittenaar\, Director of Data Science and AI\, Surgo Foundation: COVID-19 Community Vulnerability Index: Capturing the Geographical Dimensions of Vulnerability \nDr. LaToya Eaves\, Assistant Professor\, University of Tennessee: Intersectional Geographies and COVID-19 \nDr. Karen Falconer Al-Hindi\, Professor\, University of Nebraska\, Omaha \nDr. Aaron Strong\, Economist\, RAND Corporation \nPlease visit NASEM’s COVID-19 and the Geography of Vulnerability event website for more information.
URL:https://globalbiodefense.com/event/covid-19-and-the-geography-of-vulnerability/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/covid-19-georgraphy-vulnerability-nasem.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T190000
DTEND;TZID=America/New_York:20201027T203000
DTSTAMP:20201023T054154Z
CREATED:20201023T054028Z
LAST-MODIFIED:20201023T054154Z
UID:47604-1603825200-1603830600@globalbiodefense.com
SUMMARY:A Guided Exploration of COVID-19 and One Health
DESCRIPTION:The One Health Academy will host “A Guided Exploration of COVID-19 and One Health” presentation via webinar by Dr. Jessica Petrillo on October 27\, 2020. \nJessica Petrillo\, PhD is an expert on global health security policy working with diverse domestic and international stakeholders and partners to devise and implement strategic and innovative approaches to enable immediate and lasting change globally. Jessica serves as Senior Advisor for Antimicrobial Resistance (AMR) and GHSA as a Sustaining Technical and Analytic Resources Fellow at USAID with responsibility for strengthening the Agency’s technical capacity in and strategic approach to advance priority health security objectives. These include addressing the emergence\, spread\, and impact of AMR and strengthening global capacity to prevent\, prepare for\, respond to and recover from infectious disease threats including through USAID’s involvement in the National Biodefense Strategy (NBS) and Global Health Security Agenda (GHSA). Previously\, Jessica served as Senior Advisor for Health Security at the U.S. Department of State. She served as a lead for negotiating and implementing the NBS and GHSA and led the Department’s foreign policy work on AMR which included efforts to enhance action by faith-inspired organizations and the arts communities\, and improve the scientific and policy understanding of the environmental component AMR. \nDr. Petrillo received her PhD in Virology from Harvard University and conducted her postdoctoral research at the Scripps Research Institute. \nWebinar is free but you must Register here to receive your unique login link.
URL:https://globalbiodefense.com/event/a-guided-exploration-of-covid-19-and-one-health/
CATEGORIES:Webinar-Webcast
LOCATION:https://register.gotowebinar.com/register/7194478824802608908
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T113000
DTEND;TZID=America/New_York:20201028T133000
DTSTAMP:20201023T160807Z
CREATED:20201016T160257Z
LAST-MODIFIED:20201023T160807Z
UID:47625-1603884600-1603891800@globalbiodefense.com
SUMMARY:SEAN and Standing Committee on Emerging Infectious Diseases College COVID-19 Testing Strategies
DESCRIPTION:Participate in this virtual listening session on Oct. 28 focused on the landscape of current COVID-19 testing strategies. Participants will hear from representatives of several large and mid-sized colleges and universities. \nBACKGROUND \nAs part of its work advising the nation on responding to COVID-19\, the National Academies of Sciences\, Engineering\, and Medicine (NASEM) is holding a series of four public sessions to inform a forthcoming rapid expert consultation on testing strategies and capabilities at colleges and universities. \nEach session will include a framing of the issues and an overview of one or more of the major considerations that affect decisions about testing strategies and capabilities. \nA range of universities and colleges will share their experiences with COVID-19 testing\, further illustrating those considerations. \nA facilitated conversation will foster dialog among universities and colleges and with other subject matter experts and stakeholders. \nThe events are hosted by the Societal Experts Action Network (SEAN): Facilitating Rapid and Actionable Responses to Social\, Behavioral\, and Economic-Related COVID-19 Question. \nVisit NASEM’s event website for more information. \n 
URL:https://globalbiodefense.com/event/sean-and-standing-committee-on-emerging-infectious-diseases-college-covid-19-testing-strategies/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://nas-sec.zoomgov.com/webinar/register/WN_W8iXc00YQ9uGLipUXAGQAw
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T113000
DTEND;TZID=America/New_York:20201028T153000
DTSTAMP:20201024T215523Z
CREATED:20201024T215523Z
LAST-MODIFIED:20201024T215523Z
UID:47656-1603884600-1603899000@globalbiodefense.com
SUMMARY:National Virtual Biotechnology Laboratory Symposium
DESCRIPTION:The National Virtual Biotechnology Laboratory Symposium will be held Oct. 28\, 2020. \nThis online event will highlight the impact the U.S. Department of Energy’s (DOE) National Virtual Biotechnology Laboratory has had utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19\, and to discuss areas in which the National Virtual Biotechnology Laboratory can have impact in the future. \nSPEAKERS \n\nOverview of Science & Technology Challenges for COVID – NVBL Co-Leads Michelle Buchanan\, Oak Ridge National Laboratory\, and Stephen Streiffer\, Argonne National Laboratory\nFuture S&T Needs: Future of Testing & Surveillance – Bruce Tromberg\, Director\, National Institute of Biomedical Imaging & Bioengineering\, National Institutes of Health\nFuture S&T Needs: AI/ML and Computing – Jim Brase\, Deputy Associate Director for Computation\, Lawrence Livermore National Laboratory\nFuture S&T Needs: Vaccines – Greg Burel\, President\, Hamilton Grace\, LLC\nClosing Remarks – Harriet Kung\, Deputy Director for Science\, DOE Office of Science\n\nThe U.S. Department of Energy National Virtual Biotechnology Laboratory (NVBL) is a consortium of DOE National laboratories\, each with core capabilities relevant to the threats posed by COVID-19. The NVBL is taking advantage of DOE user facilities\, including light and neutron sources\, nanoscale science centers\, sequencing and bio-characterization facilities\, and high performance computer facilities\, to address key challenges in responding to the COVID-19 threat.  Examples include developing innovations in testing capabilities\, identifying new targets for medical therapeutics\, providing epidemiological and logistical support\, and addressing supply chain bottlenecks by harnessing extensive additive manufacturing capabilities.  The NVBL collaborates extensively with researchers\, both in academia and the private sector.  In addition\, the DOE user facilities are available to users in all sectors of the research community. \nRegister in advance for this webinar event.
URL:https://globalbiodefense.com/event/national-virtual-biotechnology-laboratory-symposium/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.zoomgov.com/webinar/register/WN_1nEkc3YYR2ODU-W0ZzODlA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T170000
DTEND;TZID=America/New_York:20201028T180000
DTSTAMP:20201023T161344Z
CREATED:20201023T161324Z
LAST-MODIFIED:20201023T161344Z
UID:47628-1603904400-1603908000@globalbiodefense.com
SUMMARY:Assessment of the SBIR and STTR Programs at NIH Meeting No.7
DESCRIPTION:The Seventh Meeting of the Committee on the Assessment of the SBIR and STTR Programs at the National Institutes of Health will be held virtually on Oct. 28\, 2020 5:00PM – 6:00PM ET. \nIn response to a Congressional mandate\, an ad hoc committee will conduct a study of the economic and healthcare benefits of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH) and the effectiveness of the enabling strategies NIH has employed to enhance the programs. The committee will draw on published research; existing\, available data; and case studies\, and convene a series of meetings. Specifically and to the extent that data are available\, the committee will examine: \nSBIR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available to the committee\, case studies\, and other available data\, the committee will examine whether the NIH SBIR Program is fulfilling the requirements of the enabling legislation; and study the impact and effectiveness of the enabling strategies NIH has employed to enhance the program\, including\, but not limited to\, technical and business assistance programs and the Phase IIB program. \nSTTR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available\, the committee will study how the NIH STTR Program\, including the strategies designed to enable academic entrepreneurship and innovation\, has fulfilled the requirements of the enabling legislation\, including: \n\nA review of the collaborations created between small businesses and research institutions\, including an evaluation of the effectiveness of the program in stimulating new collaborations and any obstacles that may prevent or inhibit the creation of such collaborations.\nAn evaluation of the effectiveness of the program at transferring federally funded technology and capabilities toward commercialization.\nAn examination of the non-economic impacts to businesses including measures of demographics\, participation of underrepresented groups\, and knowledge of the technical and business requirements of life science sector commercialization.\nAn analysis of whether STTR funds could be employed more effectively by the NIH STTR program to achieve the goals of the enabling legislation.\n\nEconomic and healthcare impact: The committee will examine the regional economic impacts associated with the NIH SBIR and STTR programs\, including relevant measures such as firm survival\, direct and indirect employment effects\, business revenues\, and gross value added; assess the contribution of the NIH SBIR and STTR programs to regional economic development programs and strategies\, including those around inclusivity and workforce development; and assess healthcare impacts of the NIH SBIR and STTR programs\, including an assessment of the relationship between technology outcomes supported by the NIH SBIR and STTR programs and commercially available healthcare products and services. \nThe committee will produce a consensus report with the committee’s findings and its recommendations for how to improve the programs.
URL:https://globalbiodefense.com/event/assessment-of-the-sbir-and-sttr-programs-at-nih/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201029T180000
DTEND;TZID=America/New_York:20201029T190000
DTSTAMP:20201023T144416Z
CREATED:20201023T034509Z
LAST-MODIFIED:20201023T144416Z
UID:47595-1603994400-1603998000@globalbiodefense.com
SUMMARY:Job Talk: Careers in Policy and Security
DESCRIPTION:Join the Schar School of Policy and Government and guest panelists to get an insight on how a Schar School degree can launch or advance your career in policy and security. Hear from industry experts on ways to research and build out a career roadmap from the scope of available opportunities. Panelists will share their knowledge on skills critical to preparing for professional success. \nPANELISTS: \nLarry Hanauer serves as the Vice President for Policy at the Intelligence and National Security Alliance (INSA)\, a non-profit\, non-partisan organization that promotes public-private partnerships within the national security and intelligence communities. \nCurt Gaucher has recruited intelligence professionals for several years for a number of firms and currently manages a team of recruiters as a Senior Manager of Talent Management and Strategy with the Intelligence and Homeland Security Division of General Dynamics Information Technology. \nKathleen Lackey is a Staff Officer with the Department of Defense and a 2018 graduate of the Schar School’s MA in International Security. She also served as a Graduate Student Fellow with the Schar School’s Center for Security Policy Studies. \nSaskia Popescu is a 2019 graduate of the Schar School’s PhD in Biodefense program and is a nationally recognized expert in hospital-based infection prevention. She also serves as a Term Assistant Professor in the Schar School’s graduate programs in biodefense. \nVisit the GMU Schar School website more information and to register for this event: http://bit.ly/gmuscharschooljobtalk
URL:https://globalbiodefense.com/event/job-talk-careers-in-policy-and-security/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/gmu-schar-school-security-policy-job-talk-graduate-programs-events-1280.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201104
DTEND;VALUE=DATE:20201107
DTSTAMP:20201023T150017Z
CREATED:20201023T150017Z
LAST-MODIFIED:20201023T150017Z
UID:47613-1604448000-1604707199@globalbiodefense.com
SUMMARY:6th African Conference on Emerging Infectious Diseases & Biosecurity
DESCRIPTION:The 6th African Conference on Emerging Infectious Diseases & Biosecurity will be held 4-6 November 2020 in Lagos\, Nigeria with virtual participation options. \nHighlighted conference topics this year contributing to the overarching theme of “Strengthening Africa’s Resilience in tackling emerging biosecurity threats: Lessons from COVID-19” include: \n\nBiosecurity and biothreat reduction in Africa\nClimate change and biosecurity threats in Africa\nInternational biosecurity conventions: Biological weapons\nHarnessing the digital revolution and digital platforms to advance biosecurity\nBiobanking infrastructure\nEmerging infectious diseases as an accelerating phenonmenon\nNeed for a vaccine strategy for the continent\nCultural\, Anthropological\, Social and Economic Impact of Emerging Infectious Diseases (CASE)\nRole of African governments and indigenous vaccine manufacturers in vaccine R&D\n\nPlease visit GET Africa’s 6th African Conference on Emerging Infectious Diseases & Biosecurity website for more information. \n 
URL:https://globalbiodefense.com/event/6th-african-conference-on-emerging-infectious-diseases-biosecurity/
LOCATION:The Civic Centre\, Ozumba Mbadiwe Road\, Opposite 1004\, Lagos\, 100001\, Nigeria
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201104T070000
DTEND;TZID=America/New_York:20201104T090000
DTSTAMP:20201101T235235Z
CREATED:20201022T224522Z
LAST-MODIFIED:20201101T235235Z
UID:47772-1604473200-1604480400@globalbiodefense.com
SUMMARY:Side Meeting at the 6th Global Health Security Agenda Ministerial Meeting
DESCRIPTION:The GHSA Consortium for the GHSA Task Force on Advocacy & Communications will host a Side Meeting at the 6th Global Health Security Agenda Ministerial Meeting on 4 November 2020. \nThis side event will highlight promising practices for meaningfully expanding partnerships across human\, animal\, agriculture\, and environmental sectors to improve health outcomes and local\, national\, and global health security. \nHighlighted topics include: \n\nIdentifying good\, better\, and best practices\nWildlife and environment: Connections to health security\nFostering multisectoral coordination in countries to effectively contain antimicrobial resistance\nCommunicating across sectors: Early warning systems and preparedness\nSustaining engagement with environment sector partners: Systems\, processes\, capacity and resources\n\nThe event will take place 0700-0900 EST (New York) and 1900-2100 local (Thailand). \nPlease register via the GHSA Ministerial website. Once registered\, the event will be broadcast from: https://www.ghsamm2020.com/streams/245 \nAbout GHSA \nThe Global Health Security Agenda (GHSA) 2024 Framework emphasizes the importance of engaging all relevant sectors to achieve sustainable and measurable results toward common targets for global health security. Changing conditions at local and global scales – related to deforestation and habitat loss\, wildlife trade\, and changing food systems and agricultural intensification with inadequate biosecurity – are shaping novel and increased interactions between species that facilitate opportunities for the spillover of disease. \nThe consequences are striking: more than 70% of emerging zoonotic diseases have origins in wildlife\, and climate-sensitive vector-borne diseases are appearing in new regions\, together causing extensive health and economic impact. The same drivers\, combined with the misuse and overuse of antibiotics\, have accelerated the emergence of antimicrobial resistance (AMR) among interconnected microbiomes in humans\, animals\, and the environment\, which can be spread across borders through trade\, travel\, and other movement of people and animals. Understanding the links between the environment and health risks and outcomes is critical to enhancing surveillance and detection\, develop early warning systems\, and target multisectoral risk reduction strategies to address known and novel threats. \n 
URL:https://globalbiodefense.com/event/side-meeting-at-the-6th-global-health-security-agenda-ministerial-meeting/
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/11/ghsa-side-event-global-health-security-agenda.jpg
LOCATION:https://www.ghsamm2020.com/streams/245
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201104T121500
DTEND;TZID=America/New_York:20201104T131500
DTSTAMP:20201103T012824Z
CREATED:20201003T002424Z
LAST-MODIFIED:20201103T012824Z
UID:47785-1604492100-1604495700@globalbiodefense.com
SUMMARY:FDA Virtual Town Hall Series - COVID-19 Test Development and Validation
DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for SARS-CoV-2 test developers 4 Nov 2020 from 12:15 PM – 1:15 PM Eastern. \nThe FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases\, including the Coronavirus Disease 2019 (COVID-19) pandemic. The FDA is committed to providing timely guidance to support response efforts to this pandemic. \nThe immediately in effect guidance “Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)” includes policies specific to this public health emergency. This guidance was issued on February 29\, 2020 and subsequently updated on March 16\, 2020\, May 4\, 2020\, and May 11\, 2020. \nThe FDA will also hold virtual Town Halls for test developers to help answer questions on: \n\nNovember 18\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 2\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 9\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 16\, 2020 from 12:15 pm – 1:15 pm Eastern Time\n\nLearn more
URL:https://globalbiodefense.com/event/fda-virtual-town-hall-series-covid-19-test-development-and-validation/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T120000
DTEND;TZID=America/New_York:20201105T130000
DTSTAMP:20201101T235722Z
CREATED:20201023T054551Z
LAST-MODIFIED:20201101T235722Z
UID:47610-1604577600-1604581200@globalbiodefense.com
SUMMARY:USAID: Conflict Assessment Framework
DESCRIPTION:Join HDIAC Thursday\, November 5 for a webinar presentation titled “USAID: Conflict Assessment Framework.”  \nIn order to best understand the environments where they work\, the United States Agency for International Development (USAID) uses a diagnostic tool called the Conflict Assessment Framework to analyze national and sub-national conflict. A conflict assessment is a systematic process used to analyze and prioritize the dynamics of peace\, conflict\, stability\, and instability in a given country context. The assessment consists of two stages: diagnosis and response. During the diagnosis phase\, the assessment team gathers information about the country’s internal conflict dynamics. The team then uses its findings to identify likely future scenarios that could alter a country’s risk of violent conflict. During the response stage\, the assessment team draws on its rich diagnostic analysis to formulate actionable responses. Conducting a field-based conflict assessment is challenging. It involves applying a set of rigorous analytical tasks in a dynamic process\, which must be sensitive to issues from policy positions\, organizational interests\, interpersonal and intercultural dynamics\, language\, and logistical constraints. This webinar will provide an overview of the assessment process and methods\, as well as provide illustrative examples from previously conducted field assessments.  \nPlease register in advance for the webinar.
URL:https://globalbiodefense.com/event/usaid-conflict-assessment-framework/
CATEGORIES:Webinar-Webcast
LOCATION:https://www.anymeeting.com/PIID=EF55D884864F3F
END:VEVENT
END:VCALENDAR